Sebestyén A - Search Results

1

Transcriptional characterization of the Notch signaling pathway in rodent multipotent adult progenitor cells.

Hajdu M, Luttun A, Pelacho B, Burns TC, Chase L, Gutiérrez-Pérez M, Jiang Y, Lenvik T, Vas V, Uher F, Sebestyén A, Verfaillie C. Hajdu M, et al. Among authors: sebestyen a. Pathol Oncol Res. 2007;13(4):302-10. doi: 10.1007/BF02940309. Epub 2007 Dec 25. Pathol Oncol Res. 2007. PMID: 18158565 Free article.

2

Regulation of Differentiation, Proliferation and Drug-Induced Apoptosis in HT58 Lymphoma Cells.

Mihalik R, Uher F, Peták I I, Sebestyén A, Kopper L. Mihalik R, et al. Among authors: sebestyen a. Pathol Oncol Res. 1997;3(2):100-105. doi: 10.1007/BF02907802. Pathol Oncol Res. 1997. PMID: 11173634 Free article.

3

Activity of the notch-signalling pathway in circulating human chronic lymphocytic leukaemia cells.

Hajdu M, Sebestyén A, Barna G, Reiniger L, Jánosi J, Sréter L, Várkonyi J, Demeter J, Kopper L. Hajdu M, et al. Among authors: sebestyen a. Scand J Immunol. 2007 Mar;65(3):271-5. doi: 10.1111/j.1365-3083.2006.01897.x. Scand J Immunol. 2007. PMID: 17309782 Free article.

4

Smad4-independent, PP2A-dependent apoptotic effect of exogenous transforming growth factor beta 1 in lymphoma cells.

Sebestyén A, Hajdu M, Kis L, Barna G, Kopper L. Sebestyén A, et al. Exp Cell Res. 2007 Sep 10;313(15):3167-74. doi: 10.1016/j.yexcr.2007.05.028. Epub 2007 Jun 29. Exp Cell Res. 2007. PMID: 17643425

5

Expression of TGFbeta1 and its signaling components by peripheral lymphocytes in systemic lupus erythematosus.

Kohut E, Hajdu M, Gergely P, Gopcsa L, Kilián K, Pálóczi K, Kopper L, Sebestyén A. Kohut E, et al. Among authors: sebestyen a. Pathol Oncol Res. 2009 Jun;15(2):251-6. doi: 10.1007/s12253-008-9119-8. Epub 2008 Nov 20. Pathol Oncol Res. 2009. PMID: 19020994 Free article.

6

Notch-regulation upon Dll4-stimulation of TGFb-induced apoptosis and gene expression in human B-cell non-Hodgkin lymphomas.

Hajdu M, Kopper L, Sebestyén A. Hajdu M, et al. Among authors: sebestyen a. Scand J Immunol. 2010 Jan;71(1):29-37. doi: 10.1111/j.1365-3083.2009.02346.x. Scand J Immunol. 2010. PMID: 20017807 Free article.

7

Lymphoproliferative disorders after solid organ transplantation-classification, incidence, risk factors, early detection and treatment options.

Végso G, Hajdu M, Sebestyén A. Végso G, et al. Among authors: sebestyen a. Pathol Oncol Res. 2011 Sep;17(3):443-54. doi: 10.1007/s12253-010-9329-8. Epub 2010 Dec 31. Pathol Oncol Res. 2011. PMID: 21193979 Free article. Review.

8

The activated targets of mTOR signaling pathway are characteristic for PDGFRA mutant and wild-type rather than KIT mutant GISTs.

Sápi Z, Füle T, Hajdu M, Matolcsy A, Moskovszky L, Márk A, Sebestyén A, Bodoky G. Sápi Z, et al. Among authors: sebestyen a. Diagn Mol Pathol. 2011 Mar;20(1):22-33. doi: 10.1097/PDM.0b013e3181eb931b. Diagn Mol Pathol. 2011. PMID: 21326036

9

Activity and complexes of mTOR in diffuse large B-cell lymphomas--a tissue microarray study.

Sebestyén A, Sticz TB, Márk A, Hajdu M, Timár B, Nemes K, Nagy N, Váradi Z, Kopper L. Sebestyén A, et al. Mod Pathol. 2012 Dec;25(12):1623-8. doi: 10.1038/modpathol.2012.141. Epub 2012 Aug 17. Mod Pathol. 2012. PMID: 22899290 Free article.

10

Rapamycin can restore the negative regulatory function of transforming growth factor beta 1 in high grade lymphomas.

Sebestyén A, Márk Á, Hajdu M, Nagy N, Molnár A, Végső G, Barna G, Kopper L. Sebestyén A, et al. Cytokine. 2015 Jun;73(2):219-24. doi: 10.1016/j.cyto.2015.02.024. Epub 2015 Mar 17. Cytokine. 2015. PMID: 25794661

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

220 results

Search Page

Filters